|
Source: E.Coli
Catalog No.: CYT-319
Introduction:
|
|
Transforming growth factor betas (TGFBetas) mediate many cell-cell interactions that occur during embryonic development. Three TGFBetas have been identified in mammals. TGFBeta1, TGFBeta2 and TGFBeta3 are each synthesized as precursor proteins that are very similar in that each is cleaved to yield a 112 amino acid polypeptide that remains associated with the latent portion of the molecule. This antibody reacts with the precursor and mature form of TGFBeta2 and to a lesser extent TGFBeta3, but does not cross react with TGFBeta1.
|
|
Description :
|
|
TGFB3 Human Recombinant protein encoding amino acids 644-850 and total molecular mass of 50kDa.
|
|
Synonyms:
|
|
Transforming Growth Factor-beta3, TGFB3, ARVD, FLJ16571, TGF-beta3.
|
|
Physical Appearance:
|
|
Sterile Filtered clear solution.
|
|
Formulation:
|
|
100µl purified human TGF Beta 3 protein at 100µg/ml in 50mM Tris-Acetate, pH-7.5, 1mM EDTA and 20% Glycerol
|
|
Stability:
|
|
TGF-beta 3 Human Recombinant although stable at 4 °C for 1 week, should be stored at -20 °C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please avoid freeze-thaw cycles.
|
|
Application:
|
|
(a) ELISA.
(b) Western Blotting.
(c) Inhibition Assays.
|
|
Usage:
|
|
Product is furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
|